Advertising and product promotion spending reduced 19 percent to $167 million in the quarter. Research and development expenses decreased 2 percent to $951 million in the quarter. A noncash impairment charge of $1.8 billion was contained in the quarter caused by the discontinued advancement of BMS-986094 , a nucleotide polymerase inhibitor that was in Phase II development for the treating hepatitis C. The ongoing company reported a standard tax benefit rate of 43.4 percent related to the pretax reduction in the quarter.Utilizing a large firm brush will avoid the stripy appear that can occur when you use strong shades of blusher. Lipstick – Black skin suits many different tones of lipstick so you actually do have a good range of choice with regards to this cosmetic. From bronze and nude tones for everyday wear to dramatic tones of red for night time wear you can certainly have fun tinkering with lip color.
Bayer Health care receives FDA acceptance for Stivarga to take care of colorectal cancer The U.S. Meals and Medication Administration today accepted Stivarga to take care of patients with colorectal tumor which has progressed after treatment and pass on to other areas of your body .Stivarga is a multi-kinase inhibitor that blocks several enzymes that promote cancers growth.